Nonalcoholic fatty liver disease (NAFLD) is the most common cause of chronic liver disease, and if it is accurately predicted ...

Investigators have found that the gene Asah1 plays a crucial protective role in preventing the progression of nonalcoholic fatty liver diseases (NAFLD) into more severe forms of liver disease by ...

March 15 (Reuters) - Madrigal Pharmaceuticals MDGL.O shares jumped as much as 23% on Friday after its oral drug became the first approved treatment for a fatty liver disease known as non-alcoholic ...

Because omega-3 polyunsaturated fatty acids have been shown to reduce hepatic dysfunction in NASH, but the molecular underpinnings of this action were elusive, researchers conducted a multiomic ...

NAFLD is a chronic liver disease caused by fat buildup in the liver, even with little to no alcohol use. Risk factors for NAFLD include being overweight or obese, having type 2 diabetes, high ...

For those dealing with fatty liver disease, there’s welcome news to report. Earlier this year, the United States Food and Drug Administration (FDA) approved the first and only fatty liver disease drug ...

Ozempic is well-known for its ability to manage type 2 diabetes and aid weight loss. . But as more research emerges, additional health benefits of the GLP-1 drug are being uncovered. Previous studies ...

What is fatty liver disease? The most common liver disorder in the United States, nonalcoholic fatty liver disease (NAFLD) is an accumulation of excess fat in liver cells, taking up 5 to 10 percent of ...

Liver diseases are becoming increasingly common, especially among the young generation. One of the most common conditions is non alcoholic fatty liver disease (NAFLD). Once primarily associated with ...

A new review reveals how chronic overconsumption of fructose, especially from soft drinks and ultra-processed foods, can quietly damage your liver. Diet and lifestyle change still remain the most ...